Yahoo Finance

Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity Index™ to be Presented at the San Antonio Breast Cancer ...

HOUSTON, Nov. 4, 2025 /PRNewswire/ -- Delphi Diagnostics announces the upcoming presentation of four scientific abstracts, including one platform presentation highlighting new clinical data supporting ...
Morningstar%2c Inc.

Delphi Diagnostics Appoints Eric Lindquist as Chief Financial Officer

HOUSTON, May 19, 2026 /PRNewswire/ -- Delphi Diagnostics today announced the appointment of Eric Lindquist as Chief Financial Officer, effective April 1, 2026. Mr. Lindquist brings decades of ...
Yahoo Finance

Delphi Diagnostics Announces New Publication in the European Journal of Cancer

HOUSTON, May 6, 2026 /PRNewswire/ -- Delphi Diagnostics today announced the publication of new clinical data in the European Journal of Cancer validating EAIRR, as a significant independent predictor ...
irblog.prnewswire.com

Delphi Diagnostics Announces New Publication Confirming EAI Predicts Benefit from Weekly Paclitaxel in HR+/HER2− Breast Cancer

HOUSTON, June 22, 2026 /PRNewswire/ -- Delphi Diagnostics today announced the publication of findings from the GEICAM/9906 clinical trial demonstrating that the company's Endocrine Activity Index (EAI ...
Morningstar%2c Inc.

Delphi Diagnostics Announces New Publication in the European Journal of Cancer

Delphi Diagnostics Inc. is a Texas-based company focused on advancing clinically valid tests for the prognosis and prediction of breast cancer treatment. Delphi Diagnostics, Inc. holds an exclusive ...